Sajad Dehnavi

Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

Ali Asadirad, Roohangiz Nashibi, Ali Khodadadi et al. · Phytotherapy Research · 2022 · 50 citations

Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line

Ali Asadirad, Kaveh Baghaei, Seyed Mahmoud Hashemi et al. · International Immunopharmacology · 2022 · 49 citations

Ct26 Cell Line, Dendritic Cell Immunotherapy, Cancer Immunosurveillance +9

Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)

Mahvash Sadeghi, Sajad Dehnavi, Moosa Sharifat et al. · Heliyon · 2024 · 29 citations · Full text

Sublingual prophylactic administration of OVA-loaded MSC-derived exosomes to prevent allergic sensitization

Ali Asadirad, Ata Ghadiri, Afshin Amari et al. · International Immunopharmacology · 2023 · 27 citations

Extracellular Vesicles, Sublingual Prophylactic Administration, Allergy +9

A significant decrease in the gene expression of interleukin-17 following the administration of synbiotic in patients with allergic rhinitis who underwent immunotherapy: A placebo-controlled clinical trial

Sajad Dehnavi, Farahzad Jabbari Azad, RezaFarid Hoseini et al. · Journal of Research in Medical Sciences · 2019 · 22 citations · Full text